Sanofi – Cop 21 - Sanofi, Committed Against Dengue Fever, a Disease Impacted by Climate Change

Primary tabs

Sanofi – Cop 21 - Sanofi, Committed Against Dengue Fever, a Disease Impacted by Climate Change

tweet me:
Sanofi – Cop 21 - Sanofi, Committed Against Dengue Fever, a Disease Impacted by Climate Change http://3bl.me/wrggx5

Multimedia from this Release

Thursday, January 7, 2016 - 10:55am

CAMPAIGN: Sanofi Global

CONTENT: Multimedia with summary

Michael Watson, VP Vaccination Policy & Advocacy chez Sanofi Pasteur, details the future evolutions of Dengue due to climate change.

Watch more Sanofi videos! Vist our YouTube page at SanofiTV

 

About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Keywords: Environment | CO2 Emissions | COP21 | Corporate Social Responsibility | Dengue Fever | France | Global Warming | Malaria | Paris | Sanofi | climate change

CAMPAIGN: Sanofi Global

CONTENT: Multimedia with summary

parse.ly